Skip to content
Recall Observatory FDA recall evidence

Drug product

Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed by GlaxoSmithKline Consumer Healthcare, LP, Moon Township, PA 15108, Made in Switzerland. 20 Count NDC: 0135-0509-04, 81 Count NDC: 0135-0509-02.

D-1246-2014

February 20, 2014

Class III

Product summary

Firm
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
Event
Event 67800
Status
Terminated
Classification
Class III
Quantity
189,900 20 ct Vials, 145,068 81 ct Vials
Official record key
drug-enforcement:D-1246-2014

Official wording

Reason: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Code information: (20 ct) Lot #14337 (exp 7/15), 14398 (exp 9/15) & 14510 (exp 9/15); (81 ct) Lot #14336 (exp 7/15), 14347 (exp 7/15), 14378 (9/15), 14563 (exp 9/15)

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    superpotent